Avrobio Inc Reports Results For The Quarter Ended In December: Earnings Summary

Tectonic Therapeutic

23/03/2023 12:04

* AVROBIO Inc  AVRO.OQ  reported a quarterly adjusted loss
of 57
cents​​ per share for the quarter ended in December. The mean
expectation of eight analysts for the quarter was for a loss
of 49 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * AVROBIO Inc's reported EPS for the quarter was a loss
of 57
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * AVROBIO Inc shares had risen by 72.5% this quarter.
    * The company reported a quarterly loss of $25.03 million.
    * Wall Street's median 12-month price target for AVROBIO Inc
is
$4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 23 at 12:04 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.49          -0.57          Missed
 Sep. 30 2022      -0.55          -0.52          Beat
 Jun. 30 2022      -0.57          -0.64          Missed
 Mar. 31 2022      -0.59          -0.68          Missed